FTV.NYSEFortive CORP

10-Q: Fortive Corporation Reports Q3 2024 Results, Announces Strategic Separation

Sentiment:

Quarterly Report


Fortive Corporation announced its Q3 2024 financial results and its plan to separate into two independent publicly traded companies by the fourth quarter of 2025.

Worse than expectedThe company's core revenue growth of 1.1% in Q3 2024 was lower than expected, with a volume decline of 1.8% offsetting some of the price increases.The Precision Technologies segment experienced a 3.7% core revenue decline in Q3 2024, indicating weaker performance in that area.The company's cash and equivalents decreased significantly from $1.88 billion at the end of 2023 to $811.3 million as of September 27, 2024.

Summary

  • Fortive Corporation's Q3 2024 sales increased by 2.7% year-over-year, reaching $1.53 billion.
  • The company's core revenue grew by 1.1%, with a 2.9% increase in pricing offset by a 1.8% volume decline.
  • For the first nine months of 2024, total sales increased by 2.9% to $4.61 billion, with core revenue up 1.2%.
  • The company reported a net income of $221.6 million for the quarter and $624.1 million for the first nine months.
  • Fortive announced its intention to separate into two independent publicly traded companies by the fourth quarter of 2025.
  • The separation will create a technology solutions company retaining the Fortive name and a global industrial company (NewCo) consisting of the Precision Technologies segment.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company shows some growth in sales and profitability, the core revenue growth is weak, and there are concerns about volume declines, increased debt, and the costs associated with the planned separation. The strategic separation is a significant event that introduces uncertainty.

Positives

  • The company experienced a 2.7% increase in sales in Q3 2024 and a 2.9% increase in sales for the first nine months of 2024.
  • Pricing increased by 2.9% in Q3 2024 and 2.6% for the first nine months of 2024.
  • The Advanced Healthcare Solutions segment showed strong growth with a 9.2% core revenue increase in Q3.
  • The company's operating profit margin was 19.3% for Q3 2024 and 19.5% for the first nine months of 2024.
  • The company generated $1.02 billion in cash from operating activities in the first nine months of 2024.
  • The company has a $2.0 billion revolving credit facility available.

Negatives

  • The company experienced a 1.8% volume decline in Q3 2024.
  • The Precision Technologies segment saw a 3.7% core revenue decline in Q3 2024.
  • The company recorded a $25.6 million loss from the Invetech Divestiture.
  • The company's net interest expense increased to $37.0 million in Q3 2024 and $119.7 million for the first nine months of 2024.
  • The company's cash and equivalents decreased from $1.88 billion at the end of 2023 to $811.3 million as of September 27, 2024.

Risks

  • The company's plan to separate into two independent companies may not be completed on the anticipated timeline or at all.
  • The company's financial results are subject to fluctuations in the cost and availability of commodities or components.
  • The company faces intense competition and may be required to reduce prices for its products and services.
  • The company's growth depends on the timely development and commercialization of new products and services.
  • The company's international operations are subject to various economic, political, and legal risks.
  • Trade relations between China and the United States could have a material adverse effect on the company's business.
  • The company's debt obligations could increase if it incurs additional debt or if interest rates rise.
  • The company's financial outlook is subject to various assumptions and risks, including ongoing geopolitical developments and events, macroeconomic conditions, and the impact of inflationary dynamics.

Future Outlook

The company anticipates revenue growth of approximately 3% for the fourth quarter of 2024 and the full year, with core revenue growth of approximately 1% for both periods. The company expects to execute a discrete restructuring plan related to the Separation beginning in the fourth quarter of 2024.

Management Comments

  • Management believes that reporting the non-GAAP financial measure of core revenue provides useful information to investors by helping identify underlying growth trends in our business and facilitating comparisons of our sales performance with our performance in prior and future periods and to our peers.
  • Management believes the exclusion of the effect of acquisitions and divestitures and currency translation may facilitate the assessment of underlying business trends and may assist in comparisons of long-term performance.

Industry Context

The company's performance is influenced by global economic conditions, technological advancements, and regulatory changes in the various industries it serves. The planned separation into two companies reflects a strategic move to focus on distinct market opportunities and growth trends.

Comparison to Industry Standards

  • Fortive's revenue growth of 2.7% in Q3 2024 is moderate compared to some high-growth technology companies but is consistent with established industrial and healthcare technology providers.
  • The company's operating profit margin of 19.3% is within the range of profitability for diversified industrial companies.
  • The company's strategic decision to separate into two companies is similar to other large conglomerates that have sought to unlock shareholder value by focusing on core businesses.
  • The acquisition of EA Elektro-Automatik Holding GmbH is a strategic move to bolster its position in the high-power electronic test solutions market, aligning with the growing demand for renewable energy and electric vehicle technologies.
  • The divestiture of Invetech's equipment design and manufacturing businesses is a strategic move to focus on core businesses and improve profitability.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Deferred Compensation PlanThe company has amended and restated the Non-Employee Directors Deferred Compensation Plan, effective January 1, 2025.2025-01-01The amended plan provides non-employee directors with the opportunity to elect to receive their Annual Retainer and the RSU component of their Annual Equity Grant in the form of cash, equity, or a combination of both.

Related Party Transactions

  • The company entered into an arms length transaction with the Fortive Foundation, pledging a charitable contribution of $20 million.

Stakeholder Impact

  • Shareholders will be impacted by the planned separation into two independent companies.
  • Employees may be affected by the restructuring plan related to the separation.
  • Customers will continue to receive products and services from the company's various segments.
  • Creditors will be impacted by the company's debt obligations and financing activities.

Next Steps

  • The company will continue to execute its strategic plan, including the separation into two independent companies.
  • The company will focus on managing costs and improving operating efficiency.
  • The company will continue to monitor market conditions and adjust its strategies as needed.
  • The company will execute a discrete restructuring plan related to the Separation beginning in the fourth quarter of 2024.

Key Dates

DateDescription
2023-01-01Start date for the Invetech Divestiture and Discrete Restructuring Plan.
2023-07-01Start date for the Discrete Restructuring Plan.
2023-09-29End date for the Discrete Restructuring Plan.
2023-12-31End date for the Invetech Divestiture and Discrete Restructuring Plan.
2024-01-02Additional $450 million drawn down on Delayed-Draw Term Loan due 2024.
2024-01-03Acquisition of EA Elektro-Automatik Holding GmbH.
2024-02-13Completion of the registered offering of Euro-denominated senior unsecured notes due 2026 and 2029 and repayment of Delayed-Draw Term Loan due 2024.
2024-03-14Sale of land and certain office buildings in the PT segment.
2024-06-29Divestiture of Invetech, excluding the Motion Solution Business.
2024-09-04Announcement of intention to separate into two independent publicly traded companies.
2024-09-27End of the third quarter of 2024.
2024-10-25Number of shares of common stock outstanding.
2025-01-01Effective date of the Amended and Restated Non-Employee Directors Deferred Compensation Plan.
2025 Q4Target completion date for the separation into two independent publicly traded companies.

Keywords

Fortive, financial results, quarterly report, strategic separation, Intelligent Operating Solutions, Precision Technologies, Advanced Healthcare Solutions, core revenue, acquisitions, divestitures, net income, share repurchase, debt, restructuring

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.